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Pmpaired Endothelial Function in Coronary Heart
isease Patients With Depressive Symptomatology
ndrew Sherwood, PHD,* Alan L. Hinderliter, MD,† Lana L. Watkins, PHD,* Robert A. Waugh, MD,*
ames A. Blumenthal, PHD*
urham and Chapel Hill, North Carolina
OBJECTIVES The purpose of this study was to assess whether depressive symptomatology was associated
with vascular endothelial dysfunction in patients with coronary heart disease (CHD).
BACKGROUND In patients with CHD, the presence of depression is associated with a two to four times
increased risk of mortality, but the disease pathways involved are uncertain. Endothelial
dysfunction is an established risk factor for cardiovascular events in patients with CHD.
METHODS Flow-mediated dilation (FMD) of the brachial artery, a measure of endothelial function, was
assessed in 143 patients (99 men, 44 women), ages 40 to 84 years (mean age, 63  10 years),
with documented CHD.
RESULTS Patients with significant depressive symptomatology, as indicated by a Beck Depression
Inventory (BDI) score 10 (n  47) showed attenuated FMD (p  0.001) compared with
patients that were not depressed (BDI 10; n  96). The use of antidepressant medication
was associated with improved FMD (p  0.05).
CONCLUSIONS The increased risk of cardiovascular events in CHD patients with elevated symptoms of
depression may be mediated, in part, by endothelial dysfunction. (J Am Coll Cardiol 2005;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.04146:656–9) © 2005 by the American College of Cardiology Foundation
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fepression is relatively common in patients with cardiovas-
ular disease (1,2). In patients with coronary heart disease
CHD), depression is associated with a two to four times
ncreased risk of cardiac mortality compared with patients
ith CHD who are not depressed (3,4). The physiologic
echanisms relating depression to cardiovascular risk are
ot known, but there is evidence that depression is associ-
ted with dysregulation of the autonomic nervous system
nd hypothalamic-pituitary-adrenal axis, blood hypercoagu-
ability, and increased inflammation (2,5).
Vascular endothelial dysfunction is another pathway
hrough which depression may increase cardiovascular risk.
ndothelial dysfunction features prominently in the devel-
pment, progression, and clinical manifestations of athero-
clerosis (6,7). Flow-mediated dilation (FMD) of the bra-
hial artery is a noninvasive index of endothelial function
hat is related to coronary vessel dysfunction (8) and is
ssociated with a wide range of cardiovascular risk factors
9). Prospective studies of patients with cardiovascular
isease indicate that endothelial dysfunction is an indepen-
ent predictor of cardiovascular events (10).
Two recent studies have reported that FMD was signif-
cantly lower in patients with major depressive disorder
ompared with healthy control subjects (11,12). Another
ecent study observed depressive symptoms to be inversely
elated to FMD in healthy postmenopausal women (13).
owever, no studies to date have evaluated the relationship
From the *Duke University Medical Center, Durham, North Carolina; and
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. This
esearch was supported by Grant HL 59672 from the National Institutes of Health,
ethesda, Maryland, and grant M01-RR-30 from the General Clinical Research
enter program, National Center for Research Resources, National Institutes of
ealth.b
Manuscript received January 4, 2005; revised manuscript received April 4, 2005,
ccepted May 27, 2005.f depression with FMD in patients with documented
HD.
ETHODS
tudy subjects. One hundred forty-three patients (99 men,
4 women), age 40 to 84 years (mean age, 63  10 years)
ith documented CHD (by previous myocardial infarction
MI], coronary artery bypass graft surgery, coronary angio-
lasty, or 75% stenosis in at least one major coronary
rtery) and recent (1 year) evidence of exercise-induced
yocardial ischemia participated in this study. Patients with
ardiomyopathy, valvular heart disease, congestive heart
ailure, severe cardiac arrhythmias, left bundle branch block,
olff-Parkinson-White syndrome, a resting blood pressure
200/120 mm Hg, ejection fraction 30%, or left main
oronary artery stenosis 50% were excluded. All study
ubjects indicated that they were sedentary at the time of
nrollment. Because study subjects were scheduled to also
ndergo stress testing to evaluate myocardial ischemia,
nti-ischemic medications (nitrates, beta-blockers, calcium
hannel blockers) were tapered and discontinued, in subjects
n whom this could be achieved safely, at least 48 h before
he present study assessments. All other medications were
ontinued as normal, with the exception of aspirin, which
as postponed on the day of testing until completion of the
MD assessment. This study was approved by the Institu-
ional Review Board at Duke University Medical Center,
nd informed consent was obtained from all participants
efore their participation.
ssessment of vascular endothelial function. Brachial
rtery FMD was assessed in the morning, after overnight
asting. Longitudinal B-mode ultrasound images of the
rachial artery, 4 to 6 cm proximal to the antecubital crease,
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August 16, 2005:656–9 Endothelial Function and Depressionere obtained using an Acuson (Mountain View, Califor-
ia) Aspen ultrasound platform with an 11-MHz linear
rray transducer. Images were obtained under the following
onditions: 1) after 10 min of supine relaxation; 2) during
eactive hyperemia, induced after inflation for 5 min to
uprasystolic pressure (200 mm Hg) of an occlusion cuff
laced around the forearm; 3) after a second 10-min period
f supine relaxation; and 4) after the administration of 400
g sublingual glyceryl trinitrate (GTN) spray. End-diastolic
mages were stored to magnetic-optical disk, and arterial
iameters were measured as the distance between the
rterial wall intima-media interfaces using PC-based soft-
are (Brachial Analyzer Version 4.0, Medical Imaging
pplications LLC, Iowa City, Iowa). The FMD was
efined as the maximum percent change in arterial diameter
rom 10 to 120 s post-deflation of the occlusion cuff.
Abbreviations and Acronyms
ANCOVA  analysis of covariance
BDI  Beck Depression Inventory
CHD  coronary heart disease
FMD  flow-mediated dilation
GTN  glyceryl trinitrate
GTN-D  glyceryl trinitrate dilation
LDL  low-density lipoprotein
MI  myocardial infarction
Table 1. Study Sample Characteristics
Depresse
(n 
Gender, % female
Age, yrs 60
Weight, kg 85.8
Height, m 1.69
BMI, kg/m2 29.9
SBP, mm Hg 136
DBP, mm Hg 76
Hypertension, %
Ejection fraction, % 58
HDL, mg/dl 47.1
LDL, mg/dl 113.6
Triglycerides, mg/dl 163.7
History of hypercholesterolemia, %
Smokers, %
Family history of CHD, %
BDI score 16
Resting brachial artery diameter, mm 4.36
Beta-blockers, %
Calcium channel blockers, %
Nitrates, %
Statins, %
ACE inhibitors, %
Diuretics, %
Diabetes, %
Antidepressants, %
Blood pressures and lipids were recorded after withdrawal f
medications continued as normal).
ACE  angiotensin-converting enzyme; BDI  Beck Dep
disease; DBP  diastolic blood pressure; HDL  high-density lipop
pressure.lyceryl trinitrate dilation (GTN-D) was defined as peak
ercent change in arterial diameter 3 to 5 min after the
dministration of GTN. Assessments of FMD and
TN-D were performed by personnel who were blinded to
epression status.
ssessment of depression symptoms. The Beck Depres-
ion Inventory (BDI) is a 21-item self-reported measure of
epressive symptomatology (14). A score of 10 or greater is
onsidered an indication of clinically significant depressive
ymptoms (15,16) and is associated with poorer prognosis in
atients with CHD (17). Although it is not a basis for the
linical diagnosis of depression, in the current report a BDI
10 was used to categorize subjects as “depressed.”
tatistical analyses. Characteristics of depressed and non-
epressed subjects were compared using the Student t test
nd chi-square test. Analysis of covariance (ANCOVA) was
sed to evaluate the effects of depression on FMD and
TN-D. A probability value of p  0.05 was used to
enote statistical significance.
ESULTS
linical characteristics. Forty-seven patients (33%) met
he BDI criteria (10) for significant depressive symptom-
tology, and 96 subjects were not depressed (BDI 10).
linical characteristics of the study sample are summarized
n Table 1. The depressed group was younger (p  0.012),
I >10 Non-Depressed BDI <10
(n  96) p Value
24 0.013
64  10 0.012
.2 88.4  17.6 0.422
11 1.73  0.90 0.027
3 29.4  4.8 0.595
138  18 0.455
77  8 0.540
55 0.820
58  10 0.832
.4 46.4  12.6 0.149
.4 103.1  26.9 0.045
.7 152.3  71.9 0.460
90 0.676
9 0.185
64 0.430
4  3 0.0001
74 4.49  0.91 0.353
17 0.714
5 0.445
6 0.355
72 0.640
43 0.387
20 0.109
14 0.383
8 0.0001
itrates, beta-blockers, and calcium channel blockers (other
Inventory; BMI  body mass index; CHD  coronary heartd BD
47)
55
 10
 19
 0.
 5.
 22
 9
53
 11
 10
 34
 78
87
17
70
 5
 0.
19
8
10
68
36
32
19
45
rom n
ression
rotein; LDL  low-density lipoprotein; SBP  systolic blood
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Endothelial Function and Depression August 16, 2005:656–9omprised a greater proportion of women (p  0.013), and
ad higher low-density lipoprotein (LDL) cholesterol
evels (p  0.045) than nondepressed subjects. Twenty-
ight subjects were taking antidepressant medication,
ith most (n  21) taking a selective serotonin reuptake
nhibitor.
ndothelial function. The effect of depression on FMD
as evaluated by ANCOVA, with age, gender, baseline
rterial diameter, and cardiovascular and antidepressant
edications included as covariates. As shown in Figure 1,
MD was significantly impaired in depressed compared
ith nondepressed subjects (adjusted means  SE: 4.36 
.75% vs. 7.46 0.89%, p 0.001). Because patients in the
epressed group exhibited higher LDL cholesterol levels
Table 1), we also considered LDL as a covariate. However,
DL was unrelated to FMD (p  0.318) in our sample and
ad negligible impact on the relationship between depres-
ion and FMD (p  0.001 vs. p  0.004). Antidepressant
edication use was associated with improved FMD com-
ared with subjects not taking antidepressants (adjusted
eans  SE: 6.90  0.9% vs. 4.93  0.7%, p  0.038).
here was no significant interaction between depression
tatus and antidepressant medication use (p  0.14). Age
nd baseline arterial diameter also were significant determi-
ants of the FMD response (p  0.001 and p  0.0005,
espectively) in the ANCOVA model.
Glyceryl trinitrate dilation was evaluated using the same
forementioned ANCOVA model described for FMD.
either depression nor antidepressant medication use was a
ignificant determinant of GTN-D (depressed vs. nonde-
ressed GTN-D  12.2  1.3% vs. 14.3  1.5%, p 
.143; medication vs. no medication GTN-D  12.1 
.5% vs. 14.4  1.2%, p  0.187). Age and baseline
rterial diameter were the only significant factors related
o the GTN response (p  0.0008 and p  0.0001,
igure 1. Flow-mediated dilation (FMD) in 47 depressed (Beck Depres-
ion Inventory 10) and 96 nondepressed (Beck Depression Inventory
10) patients with coronary heart disease (adjusted means  SEM).espectively). wISCUSSION
he present study found that CHD patients with elevated
ymptoms of depression exhibited impaired endothelial
unction compared with nondepressed CHD patients. To
ur knowledge, this evidence of an attenuated FMD re-
ponse associated with depression is the first documentation
f the phenomenon in a CHD population and extends
revious observations that depression is associated with
ndothelial dysfunction in otherwise-healthy individuals
11–13). The observed association of elevated symptoms of
epression with attenuated FMD, but not with GTN-D,
uggests that vascular functional impairment was not gen-
ralized but specific to the endothelium (9).
Recent evidence suggests that impaired endothelial func-
ion may be an independent predictor of cardiovascular
vents. Neunteufl et al. (18) studied 73 patients with angina
ndergoing cardiac catheterization and found FMD to be
n independent predictor of death and MI during a five-year
ollow-up period. Heitzer et al. (19) found that endothelial
ysfunction predicted cardiovascular events (death, MI,
troke, coronary revascularization) during a 4.5-year mean
ollow-up period in 281 patients with CHD. Similar pro-
pective observations have been made in patients with CHD
20), untreated hypertension (21), and documented periph-
ral vascular disease (22). This evidence has led to the
uggestion that endothelial dysfunction provides a “barom-
ter” of cardiovascular risk (23). Our present observations
aise the possibility that depression may impart an increased
isk of cardiovascular events in patients with CHD because
f its association with endothelial dysfunction. However,
he cause-effect nature of the relationship between depression
nd endothelial dysfunction cannot be deduced from these
ross-sectional data. Also, it is unclear whether endothelial
ysfunction is a direct pathway relating depression to cardio-
ascular risk or simply represents a marker of other cardiovas-
ular risk factors related to endothelial dysfunction (9).
Currently, there is no evidence to indicate that successful
reatment of depression may be accompanied by improved
ndothelial function or the amelioration of cardiovascular
isk associated with depression. Results from the Enhancing
ecovery in Coronary Heart Disease Patients (ENRICHD)
rial (24) revealed that despite modest improvements in
epressive symptoms in patients treated with cognitive
ehavior therapy, there was no effect on subsequent risk of
atal and recurrent coronary events. However, patients who
eceived antidepressant medication had better survival com-
ared with patients not receiving medication (24). In the
ertraline Antidepressant Heart Attack Randomized Trial
SADHART) (25), after 24 weeks of treatment with
ertraline or placebo, there was no difference in reduction of
epressive symptoms as measured by the Hamilton Rating
cale in the main analysis of 369 CHD patients with major
epressive disorder; however, the incidence of severe cardiac
vents was only 14.5% in the sertraline group compared
ith 22.4% in the placebo group. Our present finding that
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August 16, 2005:656–9 Endothelial Function and Depressionntidepressant medication use was associated with improved
MD raises the possibility that antidepressants may lower
ardiovascular risk in part through favorable alterations in
ascular endothelial function. Future studies examining the
mpact of treatments for depression on endothelial function
nd cardiovascular risk are warranted.
eprint requests and correspondence: Dr. Andrew Sherwood,
ox 3119, Duke University Medical Center, Durham, North
arolina 27710. E-mail: sherw002@mc.duke.edu.
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